Canadian founders frequently say they will approach US investors "once we are bigger," as though foreign capital were a weight class you train up to. The observation underneath is real — plenty of US funds genuinely will not look north — but the conclusion is mostly wrong.
Funds explicitly focused on Canada, from outside Canada. Maple VC is the clearest example: a US-based fund whose thesis is Canadian founders. These exist in greater numbers than founders expect and are actively looking. They are also usually missing from Canadian investor lists, because those lists are built on the geography of the fund rather than the geography of the cheque.
Funds with a Canadian office. Versant Ventures has been in Vancouver for years. Once a firm has people on the ground here, the cross-border objection has already been answered.
Funds and angel groups with no geographic restriction. Several state so in their own published criteria — not "exceptions considered," but no restriction at all. These are the most commonly skipped, because a restriction that does not exist leaves no trace to find.
Some US funds require a US entity, a US-resident founder, or both. Those are real constraints and worth establishing early rather than discovering in a second meeting.
Sometimes they are solvable by structuring, which is a conversation with a cross-border lawyer rather than a fundraising tactic, and which has tax consequences that outlive the round. Sometimes they are not solvable and you move on — a fast no is a gift.
Worth separating two things that are often confused: a US-incorporated entity and a US-citizen founder are different requirements. Some programmes need one, some need both. US federal programmes such as SBIR and STTR typically require a US-organised entity and majority US-citizen or permanent-resident ownership, so a Delaware subsidiary alone does not open them.
It is a maintenance problem rather than a market gap. Assembling the register of foreign investors who fund Canadian companies is not one search — it is several hundred small verifications, each of which decays. A fund opens a Toronto office. A thesis shifts. A partner leaves and takes the Canadian interest with them. A directory built in January is materially wrong by June, which is why the lists you can find are full of dead links and departed people.
So it gets rebuilt from scratch, badly, by every founder in the country, one spreadsheet at a time.
Cross-border investors are a tracked category inside our 159 verified investors, each checked against public sources and date-stamped, and re-verified on a rolling monthly cycle. It is the most-requested part of every Capital Roadmap we build, which tells you something about how badly it is missing elsewhere.
Other questions founders ask us
What non-dilutive funding is available for Canadian healthcare startups? →SR&ED vs IRAP, and should I apply for grants or pitch investors first? →How do I find angel investors in Canada for a health tech startup? →What do the regulatory classifications mean, and why do they change my investor list? →Do Canadian companies qualify for Y Combinator and US accelerators? →What is the difference between an accelerator and an incubator? →What does investment-ready actually mean? →If you are ready to move from general education to actionable insight for your own company, consider your own Capital Roadmap. 159 verified investors and 63 non-dilutive programmes, filtered to your stage, sector and province, with everyone you have already pitched removed — and a guarantee of at least five qualified investors you have not approached, or your money back.
See what matches your company →
Information, not advice. Profiles are compiled from public sources and verified on the date shown; always confirm details with the source before relying on them.